Arcutis Biotherapeutics, Inc. · NASDAQ:ARQT
BlackRock, Inc. reported a 14.10% stake in Arcutis Biotherapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Oct 5, 2026
BlackRock, Inc. reported a 14.10% stake in Arcutis Biotherapeutics, Inc., 17,751,435 shares, as a passive investor on Sep 30, 2026. Filed Oct 5, 2026 (Schedule 13G/A).
- Stake
- 14.10%
- Shares
- 17,751,435
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 14.10% | 17,751,435 |